MiR-326: Promising Biomarker for Cancer

MicroRNAs (miRNAs) are small non-coding and highly conserved RNAs that act in biological processes including cell proliferation, invasion, apoptosis, metabolism, signal transduction, and tumorigenesis. The previously identified miRNA-326 (miR-326) has been reported to participate in cellular apoptos...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yao-Jie, Wan, Jian, Wang, Chun-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912009/
https://www.ncbi.nlm.nih.gov/pubmed/31849530
http://dx.doi.org/10.2147/CMAR.S223875
_version_ 1783479367319420928
author Pan, Yao-Jie
Wan, Jian
Wang, Chun-Bin
author_facet Pan, Yao-Jie
Wan, Jian
Wang, Chun-Bin
author_sort Pan, Yao-Jie
collection PubMed
description MicroRNAs (miRNAs) are small non-coding and highly conserved RNAs that act in biological processes including cell proliferation, invasion, apoptosis, metabolism, signal transduction, and tumorigenesis. The previously identified miRNA-326 (miR-326) has been reported to participate in cellular apoptosis, tumor growth, cell invasion, embryonic development, immunomodulation, chemotherapy resistance, and oncogenesis. This review presents a detailed overview of what is known about the effects of miR-326 on cell invasion, metastasis, drug resistance, proliferation, apoptosis, and its involvement in signaling pathways.
format Online
Article
Text
id pubmed-6912009
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-69120092019-12-17 MiR-326: Promising Biomarker for Cancer Pan, Yao-Jie Wan, Jian Wang, Chun-Bin Cancer Manag Res Review MicroRNAs (miRNAs) are small non-coding and highly conserved RNAs that act in biological processes including cell proliferation, invasion, apoptosis, metabolism, signal transduction, and tumorigenesis. The previously identified miRNA-326 (miR-326) has been reported to participate in cellular apoptosis, tumor growth, cell invasion, embryonic development, immunomodulation, chemotherapy resistance, and oncogenesis. This review presents a detailed overview of what is known about the effects of miR-326 on cell invasion, metastasis, drug resistance, proliferation, apoptosis, and its involvement in signaling pathways. Dove 2019-12-11 /pmc/articles/PMC6912009/ /pubmed/31849530 http://dx.doi.org/10.2147/CMAR.S223875 Text en © 2019 Pan et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Pan, Yao-Jie
Wan, Jian
Wang, Chun-Bin
MiR-326: Promising Biomarker for Cancer
title MiR-326: Promising Biomarker for Cancer
title_full MiR-326: Promising Biomarker for Cancer
title_fullStr MiR-326: Promising Biomarker for Cancer
title_full_unstemmed MiR-326: Promising Biomarker for Cancer
title_short MiR-326: Promising Biomarker for Cancer
title_sort mir-326: promising biomarker for cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912009/
https://www.ncbi.nlm.nih.gov/pubmed/31849530
http://dx.doi.org/10.2147/CMAR.S223875
work_keys_str_mv AT panyaojie mir326promisingbiomarkerforcancer
AT wanjian mir326promisingbiomarkerforcancer
AT wangchunbin mir326promisingbiomarkerforcancer

Ejemplares similares